Strata Critical Medical Raises FY2026 Sales Guidance from $255.000M-$270.000M to $260.000M-$275.000M
Benzinga Newsdesk 8 months ago
NewsGuidance
Strata Critical Medical (NASDAQ:SRTA) raises FY2026 sales outlook from $255.000 million-$270.000 million to $260.000 million-$275.000 million.
Strata Critical Medical (NASDAQ:SRTA) raises FY2026 sales outlook from $255.000 million-$270.000 million to $260.000 million-$275.000 million.